Form: SC 13G

Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

July 29, 2024

 

Exhibit 99.1

 

JOINT FILING AGREEMENT

 

The undersigned hereby agree that statements on Schedules 13G and/or 13D and Forms 3, 4 and 5 with respect to the securities of LENZ Therapeutics, Inc. and any amendments thereto signed by each of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended. The undersigned hereby further agree that this Joint Filing Agreement may be included as an exhibit to such statements or amendments. This Joint Filing Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

 

Dated: July 29, 2024

 

    Ridgeback Capital Investments L.P.
     
    By: Ridgeback Capital Investments LLC,
    Its General Partner
     
  By: /s/ Nicole Venezia
    Name: Nicole Venezia
    Title: General Counsel
     
    Ridgeback Capital Investments LLC
     
  By: /s/ Nicole Venezia
    Name: Nicole Venezia
    Title: General Counsel
     
    Ridgeback Capital Management LLC
     
  By: /s/ Nicole Venezia
    Name:   Nicole Venezia
    Title: General Counsel